CaniFlu-Max(Canine Influenva vaccine H3N2)

 
 
 

Canine Influenza Vaccine


Product Overview

It is a vaccine created by first increasing the canine influenza virus (H3N2) in sensitive cells, separating the virus from the culture fluid and inactivating it, using an ultrafiltration apparatus to concentrate antigen components sufficiently, and finally adding an adjuvant.


Pain relief

·Efficient virus concentration technology
·Pain relief during an IM injection
·Convenient vaccination during an IM injection thanks to reduced volume (0.5ml)


High titer

·Manufacturing using a cell culture
·Effective adjuvant
·Greater than 2^7 HA/dose
·Volume is reduced but titer is increased